Sign Out
Reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension.
As monotherapy in patients in whom topical beta-blocker therapy is contraindicated.
As adjunctive therapy to other intraocular pressure lowering medications when the target IOP is not achieved with a single agent (see Pharmacology: Pharmacodynamics under Actions).
Continue with Google